XML 42 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Fair Value Considerations (Tables)
12 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of fair value on a recurring basis
           Fair Value Measurements at June 30, 2019  
     Fair Value at June 30, 2019      Quoted Priced in Active Markets for Identical Assets (Level 1)      Significant Other Observable Inputs(Level 2)      Significant Unobservable Inputs(Level 3)  
 Recurring:                        
 Warrant derivative liability     13,000     $ -     $ -     $ 13,000  
 Contingent consideration     23,326,000     $ -     $ -     $ 23,326,000  
      23,339,000       -       -       23,339,000  

 

           Fair Value Measurements at June 30, 2018  
     Fair Value at June 30, 2018      Quoted Priced in Active Markets for Identical Assets (Level 1)      Significant Other Observable Inputs(Level 2)      Significant Unobservable Inputs(Level 3)  
 Recurring:                        
 Warrant derivative liability     94,000     $ -     $ -     $ 94,000  
 Contingent consideration     4,694,000     $ -     $ -     $ 4,694,000  
      4,788,000       -       -       4,788,000  
Schedule of significant assumptions in valuing the warrant derivative liability
    As of June 30, 2019     As of June 30, 2018     At Issuance  
 Warrant Derivative Liability                  
 Volatility     163.2 %     173.4 %     188.0 %
 Equivalent term (years)     3.13       4.13       5.00  
 Risk-free interest rate     1.71 %     2.69 %     1.83 %
 Dividend yield     0.00 %     0.00 %     0.00 %
Schedule of reconciliation of changes in the warrant derivative liability
     Liability Classified Warrants  
       
 Balance as of June 30, 2017   $ -  
    Warrant issuances     4,118,000  
    Warrant exercises     (40,000 )
    Change in fair value included in earnings     (3,984,000 )
 Balance as of June 30, 2018   $ 94,000  
    Change in fair value included in earnings     (81,000 )
 Balance as of June 30, 2019   $ 13,000  
Schedule of changes in the contingent consideration
     Contingent Consideration  
       
 Balance as of June 30, 2016   $ 3,869,000  
     Increase due to purchase of assets     1,927,000  
     Increase due to accretion     306,000  
     Increase due to remeasurement     2,256,000  
     Decrease due to impairment     (710,000 )
 Balance as of June 30, 2017   $ 7,648,000  
     Increase due to purchase of assets     2,846,000  
     Increase due to accretion     801,000  
     Decrease due to contractual payment     (266,000 )
     Decrease due to remeasurement     (6,335,000 )
 Balance as of June 30, 2018   $ 4,694,000  
     Increase due to purchase of assets     8,833,000  
     Increase due to accretion     516,000  
     Decrease due to contractual payment     (548,000 )
     Increase due to remeasurement     9,831,000  
 Balance as of June 30, 2019   $ 23,326,000  
Schedule of assumption for valuing contingent consideration

   

As of

June 30,

2019

   

As of

June 30,

2018

 
 Natesto            
 Relevered Beta     0.83       0.99  
 Maket risk premium     5.50 %     5.50 %
 Risk-free interest rate     3.50 %     4.00 %
 Discount     10.20 %     10.40 %

 

   

As of

June 30,

2019

   

As of

June 30,

2018

 
 ZolpiMist            
 Relevered Beta     1.16       1.07  
 Maket risk premium     5.50 %     5.00 %
 Risk-free interest rate     3.50 %     3.50 %
 Discount     10.20 %     10.40 %

 

   

As of

June 30,

2019

    At Issuance  
 Tuzistra            
 Relevered Beta     1.19       1.49  
 Maket risk premium     5.50 %     5.00 %
 Risk-free interest rate     3.50 %     3.50 %
 Discount     20.20 %     20.40 %